Monthly Archives - November 2020

FDA Clears Neuraly to Begin Phase 2 Trial of NLY01 in Alzheimer’s Patients

The U.S. Food and Drug Administration has given clearance for a Phase 2B clinical trial to evaluate the safety, tolerability, and efficacy of Neuraly’s investigational therapy NLY01 in people with Alzheimer’s disease. The randomized, double-blinded, placebo-controlled trial is expected to enroll more than 500 people with mild cognitive impairment due to Alzheimer’s disease at more than 100 sites in the U.S., Canada, and Europe. Read more >>

Myomo Introduces MyoGames – Video Games Played via MyoPro for Training, Rehabilitation and Fun

Myomo, Inc., a wearable medical robotics company offering increased functionality for individuals suffering from neurological disorders and upper-limb paralysis, announced today the availability of MyoGames by Lusio, a video game platform designed to augment training and rehabilitation for MyoPro users, while being fun. Read more >>

A Time to be Thankful!

This is the time of year when we count our blessings!

We are blessed to have such a great community and especially during these difficult times. The year 2020 will be one of the toughest!

This is also a time to support our partner BUILD!

Please take a moment and make a donation for Thanksgiving!

Thank you to our partners, entrepreneurs, members and team from the Boston Harbor Angels!

Corbus Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat at the Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 12:35 PM EST. Read more >>

Feast or famine? Natural foods companies grapple with COVID realities

While everyone needs to eat — pandemic or no pandemic — and grocery stores have mostly thrived through the COVID-19 outbreak, the virus has created some unique challenges for the Boulder Valley region’s natural and organic product makers…“We’re trying to beat Clorox to those empty shelves,” 1908 Brands CEO Steve Savage said. 1908 is the parent company behind the Boulder Clean line of cleaning supplies. Read more >>

Neuraly Announces Strategic Sponsored Research Agreement with the University of Pennsylvania to Explore use of NLY01 to Therapeutically Target a Neuroinflammatory Mechanism of Glaucoma

Neuraly, Inc, a clinical-stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced a strategic sponsored research agreement with the University of Pennsylvania to study the use of NLY01 to therapeutically target a neuroinflammatory mechanism of glaucoma. Read more >>